Steven Shea, M.D., M.S., is the Program Director. Dr. Shea is a Hamilton Southworth Professor of Medicine and Professor of Epidemiology (in Biomedical Informatics), Chief of the Division of General Medicine and Senior Vice Dean at P&S. Dr. Shea's research interests are in cardiovascular epidemiology and prevention, and in use of computers and computing systems to improve health care delivery. He is currently principal investigator of the multi-ethnic study of atherosclerosis ( MESA ) and Informatics for Diabetes Education and Telemedicine (IDEATel) research projects.
R. Graham Barr, M.D., Dr.P.H., is Irving Assistant Professor of Medicine and Epidemiology. Dr. Barr’s research focuses primarily on the respiratory epidemiology of asthma and chronic obstructive pulmonary disease (COPD). He leads studies on the role of endothelial dysfunction and systemic inflammation in obstructive lung disease in the MultiEthnic Study of Atherosclerosis (MESA), and dietary factors, systemic inflammation and COPD in a cohort of current and former smokers (EMCAP). He has additional interests in the potential of drugs such as over-the-counter analgesics to modulate host responses in obstructive lung disease, air pollution, and clinical epidemiologic methods.
Jose Luchsinger, M.D., M.P.H., is a graduate of the general medicine fellowship program in 1999. He is a Florence Irving Associate Professor of Medicine and Epidemiology in the Gertrude H. Sergievsky Center and Taub Institute for Research on Alzheimer's disease and the Aging Brain. His main focus is epidemiological research in the associations of vascular risk factors and diet to cognitive disorders. He is the principal investigator of several projects including one exploring the associations of vascular and cerebrovascular disease to Alzheimer's disease and mild cognitive impairment, a cohort study of cognitive impairment in elderly persons with type 2 diabetes, and a clinical trial of metformin in persons with mild cognitive impairment. Dr. Luchsinger also has a leading role in cognitive assessments in the landmark Diabetes Prevention Program Outcomes Study and the Finnish Diabetes Prevention Study.
Karina Davidson, Ph.D., is the Herbert Irving Associate Professor of Behavioral Medicine in Medicine and Psychiatry, and the Interim Director of the Center for Behavioral & Cardiovascular Health within the Division. She is also the Associate Director of the Clinical & Translational Science Award at Columbia University. Her research focuses the biopsychosocial mechanisms explaining why behavioral and anger and depression predict worse outcomes for patients with cardiovascular disease. She is the Principle investigator on one set of studies (COPES) examining the etiologies, mechanisms and treatments by which depression confers prognostic risk in acute coronary syndrome patients, and on a program project (PULSE) examining novel depression phenotypes and their pathophysiological and behavioral mechanisms underlying ACS recurrence risk. She has conducted randomized controlled trials of anger management and depression treatment for both hypertensive and post-myocardial infarction patients, examining their impact on clinical outcomes.
Kathleen Donohue, M.D., is an Instructor of Medicine in the Division of General Medicine. Her research focuses primarily on the role of systemic inflammation and environmental risk factors in respiratory disease in the MultiEthnic Study of Atherosclerosis.
Andrew Moran, M.D., M.P.H, Andrew Moran M.D., M.P.H. is an Assistant Professor in the Division. His primary research interest is in cardiovascular disease and related health policy decisions in developing nations. Dr. Moran's main projects are a computer cardiovascular disease policy model for China and the systematic review of ischemic heart disease for the 2005 Global Burden of Disease Study.
Daichi Shimbo, M.D.,
Joseph Schwartz, Ph.D.,
Peter Stetson, M.D.,